Skip to main content
. 2022 Oct 12;22(2):205–214. doi: 10.1158/1535-7163.MCT-22-0012

Table 1.

Inhibitory activities of tinengotinib on human kinases.

Kinase IC50/nmol/L Kinase IC50/nmol/L
Aurora A 1.2 KDR 2.5
Aurora B 3.3 VEGFR3 0.93
FGFR1 2.3 JAK1 15
FGFR2 1.5 JAK2 0.75
FGFR3 3.5 CSF1R 7.0
VEGFR1 2.4